Isabel Chirivella

OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study

Christophe Tournigand, Andrés Cervantes, Arié Figer et al. · Journal of Clinical Oncology · 2006 · 805 citations

Medicine, Oncology, Pharmacology +15

Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients

Isabel Chirivella, Begoña Bermejo, Amelia Insa et al. · Breast Cancer Research and Treatment · 2008 · 174 citations · Full text

Medicine, Oncology, Pharmacology +16

Reintroduction of Oxaliplatin Is Associated With Improved Survival in Advanced Colorectal Cancer

Aimery de Gramont, Marc Buyse, José Cortiñas Abrahantes et al. · Journal of Clinical Oncology · 2007 · 133 citations

Medicine, Oncology, Pharmacology +11

SEOM clinical guidelines in Hereditary Breast and ovarian cancer

Gemma Llort, Isabel Chirivella, Rafael Morales et al. · Clinical & Translational Oncology · 2015 · 118 citations · Full text

Medicine, Genetics, Oncology +15

Phase I Safety, Pharmacokinetics, and Inhibition of Src Activity Study of Saracatinib in Patients with Solid Tumors

José Baselga, Andrés Cervantes, Erika Martinelli et al. · Clinical Cancer Research · 2010 · 109 citations

Medicine, Oncology, Pharmacology +15